Home › Free Stock Grades › GILD
Gilead Sciences, Inc. (GILD) Stock Grade
GILD · Healthcare
A+
Market Cap
$171.8B
P/E Ratio
17.9
Revenue Growth (YoY)
+2.4%
Net Margin
28.9%
Return on Equity
37.5%
Dividend Yield
2.7%
About Gilead Sciences, Inc.'s fundamentals
Gilead Sciences is a large-cap pharmaceutical company with a $152.7 billion market valuation and a P/E ratio of 17.9, indicating moderate valuation relative to its earnings. The company demonstrates strong profitability with a net margin of 28.9% and an impressive return on equity of 37.5%, showing efficient capital deployment. Revenue growth has been modest at 2.4% year-over-year, and the company returns capital to shareholders through a 2.6% dividend yield.